Bacterial diseases, causative organisms, and their crustacean hosts.
Abstract
Phage therapy is one of the most important control strategies envisaged for the management of bacterial diseases in the aquatic environment. There are no other effective alternative approaches for the natural control of bacterial diseases, while phage therapy remains the best method which has not yet been exploited. The occurrence, infectivity, lytic activities, therapeutic potentials, and efficacy of the bacteriophages of Bacillus spp./Vibrio spp. for control of pathogenic bacteria diseases such as Vibrio vulnificus, V. damsela, and V. furnissii in the cultures of crustaceans are presented. An ideal method for long-term storage and recovery of the lytic bacteriophages, agar bioassay method and one-step growth experiments, in vivo and in vitro experiments, and validation of the usefulness of phage therapy are described. The review highlights the occurrences of plagues of lytic phages of Vibrio sp. and Bacillus spp. and their control effects of vibriosis both in vivo and in vitro in the crustaceans, thus establishing the application and efficacy of the phages of Vibrio/Bacillus against the pathogenic Vibrio spp. Development of specific phage therapy or a cocktail of phages to a wide variety of systems is considered to represent an interesting emerging alternative to antibiotic therapy and vaccination.
Keywords
- phage therapy
- bacterial diseases
- vibriosis
- probiotics
- bacteriophages
- antimicrobials
- antibiotic resistance
- crustaceans
- shrimp
- lobster
- crab
- Artemia
1. Introduction
1.1 Global crustacean production and losses due to diseases
Global fish production was 171 million tons estimated at USD 362 billion in 2016, while aquaculture production was 80.37 million tons estimated at USD 232 billion [1, 2, 3] consisting of 54.1 million tons of finfish production, 17.1 million tons of molluscs, 7.9 million tons of crustaceans, and 938,500 tons of other aquatic animals such as turtles, sea cucumbers, sea urchins, frogs, and edible jellyfish [3]. Freshwater finfish represents half of the global aquaculture production (54%), molluscs being the second more produced aquaculture item in the world (24%) [2]. Crustaceans come next in production relevance, represented mostly by penaeid shrimps and grapsid crabs [2, 3]. Aquaculture is the world’s fastest growing segment with a global increase of 5.7% per annum in shrimp production resulting in an increase of 18% by 2020, and the estimated world production of farmed shrimp is 3.5 million metric tons though the diseases, international market prices, and production costs are the main challenges and constrains to the growth and productivity of the shrimp industry on a global level [4]. However, disease outbreaks have caused serious economic losses in several countries, and the estimated global losses due to shrimp diseases are around US$ 6 billion per annum [5, 6]. Such concerns confirm that the bacterial diseases are the most important contracting factors for development of the global aquaculture industry [7].
1.2 Bacterial diseases in crustaceans
Bacteria in the aquatic environment and the bacterial diseases, viz. vibriosis, shell diseases (chitinolytic bacteria), and gaffkemia of lobsters, are ubiquitous and are significant for the survival of crustaceans in confined habitats [8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22]. Diseases, causative organisms, and their crustacean hosts are listed in Table 1. Gaffkemia of lobsters is caused by
Diseases | Hosts | Causative bacterial species |
---|---|---|
Vibriosis | ||
Bacterial fouling of surfaces with filamentous bacterial disease | ||
Shell disease, brown/black spot, black gill, black rot/erosion, blisters, necrosis of appendages | Crabs and shrimp, white and brown shrimp | Chitonoclastic bacteria |
Chitinolytic bacterial disease, shell disease, box burnt disease, bacterial shell disease | Chitinolytic or chitinoclastic bacteria (Gram-negative), viz. | |
Milky hemolymph disease (milky hemolymph syndrome [MHS]) | Spiny lobster | Rickettsia-like bacterium, a- |
Gaffkemia, septicemia | Lobsters | |
Bacteremias | Bacterial diseases of crabs | |
Fungal diseases |
2. Phage therapy
Phage therapy is a prospective ideal therapy for vibriosis in aquaculture of crustaceans. Bacteriophages are defined as bacterial viruses that can infect cells, multiply in, cytolyse, and destroy susceptible bacteria. Bacteriophages are viruses of bacteria which have a natural ability to target, infect, and destroy their host cells of a particular bacterial species or groups or even unrelated bacteria, and thus they play a major role in controlling their target bacterial population density in nature [23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60]. They are both omnipresent and copious in the aquaculture environment, especially in seawater, in which the total numbers of viruses normally surpass the bacterial cell concentration by a factor of 10 [25]. “Most phages reproduce upon entering a cell and in that process kill their host. They encode two families of proteins, holins, and lysins, which allow the phage progeny to burst through the bacterial cell wall and go off in search of new hosts. But the cell is already dead by the time that happens in terms of lethality; the lysis is just a matter of burning down the house for good measure.” An estimated 108 strains of phage with approximately 1031–1032 phages are known to occur in the biosphere at any given time [23]. Bacteriophages are used for the isolation and identification of specific bacteria to help in the diagnosis of the bacterial diseases, to kill antibiotic-resistant, virulent bacteria through a natural phenomenon called lysogeny, whereby one of the phage-infected bacteria in a colony kills another uninfected bacterium through phage missiles or antibacterial peptides [24, 25, 36, 37, 38, 39, 41].
2.1 Phage therapy, an alternative to antibiotics
Due to their specific antibacterial activities and significance of the phage therapy as an alternative to antibiotics, bacteriophage therapy is re-emerging, and consequently this has become a potentially novel and useful concept to kill even intracellular pathogenic bacteria and warrant future development. Bacteriophage therapy has been extended from medical applications into the fields of agriculture, aquaculture, and the food industry [28, 29, 30, 39]. Bacteriophages specific for
2.2 Probiotics in crustacean cultures
Probiotics are defined as applications of whole or components of microorganisms or “a live microbial adjunct which has a beneficial effect on the host by modifying the host-associated or ambient microbial community, by ensuring improved use of the feed or enhancing its nutritional value, by enhancing the host response towards disease, or by improving the quality of its ambient environment” [74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93]. A probiotic is a live microbial feed supplement which benefits the host animal by improving its intestinal microbial balance [82]. Lactic acid bacterium
2.3 Proprobiotics
Proprobiotic is defined as a synbiotic comprising pre- and probiotics involving a combination of strains of nonpathogenic bacteria and yeast so as to provide supplementary nutrients and to protect against invading pathogens. Commercially available proprobiotics are known to competitively exclude the potential pathogen through the use of proprobiotics in aquaculture. Effects of Ergosan and Vibromax are used to prevent vibriosis in
2.4 Bacillus for the control of vibriosis
Pathogenic
2.5 Antimicrobials
2.6 Antibiotic-resistant bacterial infections in crustaceans
All of the 121 isolates of
2.7 Antibiotic-resistant genes (ARGs)
A study assessed a variety of antibiotic-resistant bacteria and detected the presence of their resistance genes from mariculture environments. A variety of antibiotics that were used in aquaculture have led to the occurrence of antibiotic-resistant genes in bacteria, and in these bacteria many different ARGs can be found, and they are β-lactam- and penicillin-resistant genes
2.8 Bacteriophage therapy for biocontrol of vibriosis in crustaceans
A bacteriophage isolated from a shrimp hatchery was shown to infect
Crustacean host | Bacterial agent | Infection/disease | Bacteriophage | Source of the bacteriophage | Efficacy of bacteriophage | Outcome of the phage therapy | References |
---|---|---|---|---|---|---|---|
Shrimp larvae | Luminous vibriosis | Extracted from a toxin-producing strain of | Vibriolysis | VHML showed a narrow host range with a preference for | [100] | ||
Shrimp larvae | Luminous vibriosis | Shrimp farm waters from the West coast of India | 18-day-old PL shrimp were challenged with the bacteria (105 cells ml−1, laboratory trial: (1) bacteriophage suspension (109 pfu ml−1) was added initially; after 24 h (another 0.1 ml), (2) only once initially with 0.1 ml of the phage suspension; (3) no addition. Hatchery trial (1) treatment with bacteriophage (109 pfu ml−1) at the rate of 200 ppm daily so that phage concentration in the water was 29–105 pfu ml−1; (2) treatment with antibiotics (oxytetracycline 5 ppm, kanamycin 10 ppm daily); (3) no treatment | Enhanced survival (80%) of | [48] | ||
Larval shrimp | Luminous vibriosis | Three from oyster tissue and one from shrimp hatchery water | Hatchery tanks, with post-larval five-stage larvae, presenting luminescence and mortality, were used. Bacteriophage treatment (two tanks): one suspension (29 106 pfu ml−1) was added by day following the order: Viha10, Viha8, Viha10, and Viha8 chemotherapy (two tanks): oxytetracycline (5 mg L−1), kanamycin (10 mg L−1) | Bacteriophage treatment resulted in over 85% survival of This study shows that bacteriophages could be used for biocontrol of | [46] | ||
Penaeid shrimp | Luminous vibriosis | Seven bacteriophages specific to | Coastal aquaculture systems like shrimp farms, hatcheries, and tidal creeks along the East and West coast of India | All the phages were found to be highly lytic for | [51] | ||
Shrimp | Luminous vibriosis | Shrimp farm | All the isolates of bacteriophage (VH1–VH8) caused lysis of the host bacterial cells within 2 h. The propagation curve for each phage showed a burst time from 1 to 10 h. Bacteriophages of | [39] | |||
Shrimp | Luminous vibriosis | Shrimp pond water | Phage adsorption rate increased rapidly in the first 15 min of infection to 80% and continued to increase to 90% within 30 min of infection. The stability of phage PW2 was dependent on temperature and pH. It was inactivated by heating at 90°C for 30 min and by treating at pH 2, 3, 11, and 12. One-step growth curve and latent and burst periods were 30 and 120 min, respectively, with a burst size of 78 pfu per infected center. Six structural proteins were detected | [52] | |||
Larval shrimp | Luminous vibriosis | ϕH17-5c, ϕH17-7b, ϕH17-8b, and ϕH17-9b | Secluded from shrimp farm water from the West coast of India and demonstrated to exhibit a broad lytic activity against | In a set of laboratory experiments, post-larval | In the antibiotic (oxytetracycline 5 ppm, kanamycin 100 ppm/day)-treated hatchery tanks, an initial reduction of luminous bacterial counts were shown, and after 48 h the bacterial count increased to 106 ml−1 showing the luminous vibriosis and mortality of the nauplii of | [48, 49] | |
Shrimp, | Vibriosis | Phages VV1, VV2, VV3, and VV4 from | VV1, VV2, VV3, and VV4 phages were detected from shrimp aquaculture system | In vitro experiments show successful potential phage therapy; lytic | [36, 37, 38, 39] | ||
Phyllosoma larvae of the tropical rock lobster | Luminous vibriosis | Six bacteriophages from | Isolated from an epizootic in aquaculture-reared larval phyllosomas of the ornate spiny lobster | Exhibited a clear lytic activity against (1) Addition of phage VhCCS-06 (1 ml) 2 h after inoculation; (2) addition of phage VhCCS-06 (1 ml) 6 h after Bacteria-free supernatants were obtained by centrifugation at 10,000 | Exhibited a clear lytic activity against | [55] | |
Live prey | Vibriosis | Two novel bacteriophages | In vitro cell lysis experiments against the bacterial host | In vivo administration of the phage cocktail consisting of | [98, 99] | ||
Brine shrimp nauplii | Vibriosis of | VPMS1 phage | VPMS1 is a lytic phage of | The phage therapy was successful in preventing vibriosis; a single dosage of VPMS1 phage was effective enough to get rid of the adverse effects of | [97] | ||
Lytic phage (VVP1) belongs to the | Lytic phage (VVP1) able to infect strains of N1A and N7A, | One-step growth experiments, multiplication and host range, and pH and temperature stability of the lytic phage (VVP1) were shown; the phage showed protective biocontrol effects in reducing the pathogenic | [101] | ||||
Vibriosis, a zoonotic pathogen causing mass mortality in aquatic animals and infecting humans | Phage pVa-21, | Phage pVa-21 infects bacteria belonging to the family | Bacteriophage pVa-21 belongs to | Infect bacteria, viz. | [101] |
2.9 In vitro and in vivo effects of Bacillus against vibriosis in shrimp
In vitro and
The occurrence of phages in infected cells of
TEM analysis of the phages of
2.10 Antagonism of Bacillus against Vibrio spp.
An antagonism assay consisting of cell-free extract of
2.10.1 Long-term storage of phages
The usefulness of a phage lysate preparation and treatment method adopted for long-term storage of phages was elucidated in a study that demonstrated the infectivity of the phages of
2.10.2 Phage therapy for vibriosis in shrimp
Phage therapy is a re-emerging field, and the bacteriophages represent potential biocontrol agents for the control of virulent and drug-resistant bacteria [19, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73]. However the use of phage therapy in shrimp is still in its early years, and these are highlighted especially the need for using more than one kind of bacteriophage in aquaculture to evade development of bacterial resistance [47, 48, 49, 58, 59, 60]. Phage therapy has been effectively used to protect against
2.10.3 Phage therapy in lobsters
Significant (71%) mortalities of larval, post-larval, and adult lobsters were caused by shell diseases where
Crothers-Stomps and colleagues [55] demonstrated that from eight bacteriophages (six phages belonged to the family
2.10.4 Diseases of Macrobrachium rosenbergii (DeMan)
Bacterial and fungal diseases are accountable for the high mortality and profound economic loss encountered in the giant freshwater prawn
2.10.5 Diseases of crabs
Shell diseases are caused by chitinolytic bacteria which were encountered in English prawn
2.10.6 Phage therapy for vibriosis of Artemia salina
The occurrences of
2.10.7 In vitro lytic effect of phages φ St2 and φ Grn1 on Vibrio strains of Artemia salina
In vitro cell lysis experiment of phage (a)
2.10.8 In vivo efficacy of phages on the vibriosis of A. salina culture
The effect of the phage mixture (
3. Conclusions
The callous use of antibiotics against bacterial diseases in the culture of crustaceans in the aquatic system has led to the development of antibiotic-resistant bacterial infections which can be a serious threat to all life forms and public health, and the phage therapy may help to overcome such complex problems. Control of bacterial diseases in the future may depend on development of novel drugs, innovative approaches, and management practices to minimize the risk of introduction of infectious agents into aquaculture systems and to reduce predisposing factors. The occurrences of lytic bacteriophages of
Acknowledgments
The author (PR) is thankful to Ms. Keerthana and Mrs. Rekha for their assistance and help in the work. The author acknowledges support from Sree Balaji Medical College and Hospital for providing research facilities and encouragement for technical assistance to complete the work.
Conflict of interest
The author declares that there is no financial or conflict of interests.
Author’s contribution
The author (Dr P. Ramasamy) has made a significant contribution to the conception, design, and execution of the reported study and drafted the manuscript writing and discussion.
References
- 1.
FAO. The state of world aquaculture. Fisheries Technical Paper; 500, 2006 - 2.
FAO. The State of World Fisheries and Aquaculture—2008; 2009 - 3.
The State of World Fisheries and Aquaculture. FAO’s Official World Fishery and Aquaculture; 2018 - 4.
The shrimp panel at the National Fishery Institute’s. In: Global Seafood Market Conference (GSMC); Miami, Florida, USA; 21-25 January 2018. 2018 - 5.
Lundin GG. Fish health quarantine. In: The World Bank Report. Global Attempts to Address Shrimp Disease. Marine/Environmental Paper 4. 1996. p. 45 - 6.
Stentiford G, Sritunyalucksana K, Flegel TW, Williams BAP. New paradigms to help solve the global aquaculture disease crisis. PLoS Pathogens. 2017; 13 :2 - 7.
Sindermann CJ. Principal Diseases of Marine Fish and Shellfish. 2nd ed. Vol. 2. United Kingdom, London: Academic Press; 1990 - 8.
Baross JA, Tester PA, Morita RY. Incidence, microscopy, and etiology of exoskeleton lesions in the tanner crab, Chionoecetes tanneri . Journal of the Fisheries Research Board of Canada. 1978;35 :1141-1149 - 9.
Taylor CC. Shell disease as a mortality factor in the lobster ( Homarus americanus ). Fish Circ. Maine, Dep. Sea Shore Fish; 1948. pp. 41-48 - 10.
Malloy SC. Bacteria induced shell disease of lobsters ( Homarus americanus ). Journal of Wildlife Diseases. 1978;14 :2-10 - 11.
Roald SO, Aursjø J, Hästein T. Occurrence of shell disease in lobsters, Homarus gammarus in the southern part of the OsloFjord. Norway: FiskeriDirektoratets Skrifter Serie HavUndersokelser; 1981;17 :153-160 - 12.
Goulden EF, Hall MR, Bourne DG, Pereg LL, Høj L. Pathogenicity and infection cycle of Vibrio owensii in larviculture of the ornate spiny lobster (Panulirus ornatus ). Applied and Environmental Microbiology. 2012;78 (8):2841-2849. DOI: 10.1128/AEM.07274-11 Epub 2012 Feb 3 - 13.
Austin B, Zhang XH. Vibrio harveyi : A significant pathogen of marine vertebrates and invertebrates. Letters in Applied Microbiology. 2006;43 (2):119-124 - 14.
Molitoris E, Joseph SW, Krichevsky MI, Sindhuhardja W, Colwell RR. Characterization and distribution of Vibrio alginolyticus andVibrio parahaemolyticus isolated in Indonesia. Applied and Environmental Microbiology. 1985;50 (6):1388-1394. 0099-2240/85/121388-07$02.00/0 - 15.
Vaseeharan B, Ramasamy P. Abundance of potentially pathogenic micro-organisms in India. Penaeus monodon larval rearing hatcheries in India. Microbiological Research. 2003;158 (4):299-308 - 16.
Ramasamy P, Rajan PR, Jayakumar R, Rani S, Brennan GP. Lagenidium callinectus (Couch, 1942) infections and its control in aquacultured larval (nauplii, zoea and mysis) Indian tiger prawnPenaeus monodon . Journal of Fish Diseases. 1996;19 :75-82 - 17.
Jayakumar R, Ramasamy P. Bacterial and protozoan (ciliate) diseases of prawn Penaeus indicus (Crustacea ). Indian Journal of Marine Sciences. 1999;28 :285-296 - 18.
Krishnika A, Ramasamy P. Effect of water exchange to eliminate Vibrio sp. during the naupliar development ofArtemiafranciscana . Journal of Fisheries and Aquatic Science. 2012;7 (3):205-214 - 19.
Krishnika A, Ramasamy P. Antimicrobial resistance profile of Vibrio species isolated from the hatchery system ofMacrobrachium rosenbergii (Deman). Indian Journal of Fisheries. 2014;60 (4):147-152 - 20.
Krishnika A, Ramasamy P. Effect of chlorination, antibiotics, and UV radiation of Vibrio population in the hatchery system ofMacrobrachium rosenbergii (DeMan). Asian Journal of Microbiology, Biotechnology & Environmental Sciences. 2013;15 (1):105-112 - 21.
Krishnika A, Ramasamy P. Lagenidium sp infection in the larval stages of the fresh water prawnMacrobrachium rosenbergii (DeMan). Indian Journal of Fisheries. 2014;61 (2):90-96 - 22.
Karunasagar I, Karunasagar I, Umesha RK. Microbial diseases in shrimp aquaculture. In: Ramaiah N, editor. Marine Microbiology: Facets and Opportunities. Goa: National Institute of Oceanography; 2000. pp. 121-134 - 23.
Nakai T, Sugimoto R, Park K-H, et al. Protective effects of bacteriophage on experimental Lactococcus garvieae infection in yellowtail. Diseases of Aquatic Organisms. 1999;37 :33-41 - 24.
Børsheim KY. Native marine bacteriophages. FEMS Microbiology Ecology. 1993; 102 :141-159 - 25.
Thiel K. Old dogma, new tricks—21st century phage therapy. Nature Biotechnology. 2004; 1 :31-36 - 26.
Marks T, Sharp R. Review: Bacteriophages and biotechnology: A review. Journal of Chemical Technology and Biotechnology. 2000; 75 :6-17 - 27.
Heldal M, Bratbak G. Production and decay of viruses in aquatic environments. Marine Ecology Progress Series. 1991; 72 :205-212 - 28.
Fuhrman JA, Suttle CA. Viruses in marine planktonic systems. Oceanography. 1993; 6 :51-63 - 29.
Nakai T, Park SC. Bacteriophage therapy of infectious diseases in aquaculture. Research in Microbiology. 2002; 153 (1):13-18 - 30.
Withey S, Cartmell E, Avery LM, et al. Bacteriophages—Potential for application in wastewater treatment processes. Science of the Total Environment. 2005; 339 (1-3):1-18 - 31.
Levin BR, Bull JJ. Population and evolutionary dynamics of phage therapy. Nature Reviews. Microbiology. 2004; 2 (2):166-173 - 32.
Chanishvili N. Phage therapy—History from twort and D'Herelle through soviet experience to current approaches. Advances in Virus Research. 2012; 83 :4-40. DOI: 10.1016/B978-0-12-394438-2.00001-3 - 33.
D’Hérelle F. Surun microbe invisible antagoniste des Bacillus dysentérique. Comptes rendus de l’Académie des Sciences-Series D. 1917;165 :373-375 - 34.
Sulakvelidze A, Kutter E. Bacteriophage therapy in humans. In: Kutter E, Sulakvelidze A, editors. Bacteriophages: Biology and Application. Boca Raton: CRC Press; 2005. pp. 381-436 - 35.
Whitman WB et al. Prokaryotes: The unseen majority. Proceedings of the National Academy of Sciences. 1998; 95 :6578-6583 - 36.
Ramasamy P, Brennan GP. Phage therapy in aquaculture system. In: Trends in Biotechnology. India: University of Madras, Publication Division; 2002. pp. 53-60 - 37.
Srinivasan P, Vaseeharan B, Ramasamy P. Vibrio bacteriophages control the growth of bacterial populations in the aquatic environment. In: The Sixth Indian Fisheries Forum organized by Central Institute of Fisheries Education, Versova, Mumbai—400 061, India; during 17–20 December 2002; 16 - 38.
Srinivasan P, Ramasamy P. Effect of pH, temperature, enzymes, organic solvents and detergents in the survival and infectivity of Vibrio bacteriophages. In: Conference on Microbiology of the Tropical Seas (COMITS) National Institute of Oceanography; Goa, India during 13–15 December 2004 - 39.
Srinivasan P, Ramasamy P, Brennan GP, et al. Inhibitory effects of bacteriophages on the growth of Vibrio sp. pathogens of shrimp in the Indian aquaculture environment. Asian Journal of Animal and Veterinary. 2007;2 (4):166-183 - 40.
Vaseeharan B, Ramasamy P. Control of pathogenic Vibrio spp.Bacillus ubtilis BT23, a possible probiotic treatment for black tiger shrimpPenaeus monodon . Letters in Applied Microbiology. 2003;36 (2):83-87 - 41.
Srinivasan P, Ramasamy P. Morphological characterization and biocontrol effects of Vibrio vulnificus phages againstVibriosis in the shrimp aquaculture environment. Microbial Pathogenesis. 2017;111 :472-480 - 42.
Park SC, Shimamura I, Fukunaga M, et al. Isolation of bacteriophages specific to a fish pathogen, Pseudomonas plecoglossicida , as a candidate for disease control. Applied and Environmental Microbiology. 2000;66 (4):1416-1422 - 43.
Park SC, Nakai T. Bacteriophage control of Pseudomonas plecoglossicida infection in ayuPlecoglossus altivelis . Diseases of Aquatic Organisms. 2003;53 :33-39 - 44.
O’Flaherty S, Ross RP, Coffey A. Bacteriophage and their lysins for elimination of infectious bacteria. FEMS Microbiology Reviews. 2009; 33 (4):801-819 - 45.
Kim JH, Gomez DK, Nakai T, et al. Isolation and identification of bacteriophages infecting ayu Plecoglossus altivelisaltivelis specificFlavobacterium psychrophilum . Veterinary Microbiology. 2010;140 (1-2):109-115 - 46.
Karunasagar I, Vinod MG, Kennedy B, et al. Biocontrol of bacterial pathogens in aquaculture with emphasis on phage therapy. In: Walker PJ, Lester RG, Bondad-Reantaso MG, editors. Diseases in Asian Aquaculture V. Fish Health Section. Manila: Asian Fisheries Society; 2005. pp. 535-542 - 47.
Austin B, Stuckey LF, Robertson PAW, Effendi I, DRW G. A control agents in aquaculture. Journal of Ocean University of China. 1995; 6 (1):76-79 - 48.
Vinod MG, Shivu MM, Umesha KR, et al. Isolation of Vibrio harveyi bacteriophage with a potential for biocontrol of luminous vibriosis in hatchery environments. Aquaculture. 2006;255 (1-4):117-124 - 49.
Karunasagar I, Shivu MM, Girisha SK, et al. Biocontrol of pathogens in shrimp Hatcheries using bacteriophages. Aquaculture. 2007;268 (1-4):288-292 - 50.
Chrisolite B, Thiyagarajan S, Alavandi SV, et al. Distribution of luminescent Vibrio harveyi and their bacteriophages in a commercial shrimp hatchery in SouthIndia. Aquaculture. 2008;275 (1-4):13-19 - 51.
Shivu MM, Rajeeva BC, Girisha SK, et al. Molecular characterization of Vibrio harveyi bacterio-phages isolated from aquaculture environments along the coast of India. Environmental Microbiology. 2007;9 (2):322-331 - 52.
Phumkhachorn P, Rattanachaikunsopon P. Isolation and partial characterization of a bacteriophage infecting the shrimp pathogen Vibrio harveyi . African Journal of Microbiology Research. 2010;4 :1794-1800 - 53.
Maeda M, Liao IC. Effect of bacterial population on the growth of a shrimp larva, Penaeus monodon . Bulletin of National Research Institute of Aquaculture (Japan). 1992;21 :25-29 - 54.
Jiang SC, Kellogg CA, Paul JH. Characterization of marine temperate phage-host systems isolated from Mamala Bay, Oahu, Hawaii. Applied and Environmental Microbiology. 1998; 64 :535-542 - 55.
Crothers-Stomps C, Høj L, Bourne DG, et al. Isolation of lytic bacteriophage against Vibrio harveyi . Journal of Applied Microbiology. 2010;108 (5):1744-1750 - 56.
Wu JL, Lin HM, Jan L, Hsu YL, Chang LH. Biological control of fish bacterial pathogen, Aeromonas hydrophila by bacteriophage AH 1. Fish Pathology. 1981;15 :271-276 - 57.
Rong R, Lin H, Wang J, Khan MN, Li M. Reductions of Vibrio parahaemolyticus in oysters after bacteriophage application during depuration. Aquaculture. 2014;418-419 :171-176 - 58.
Kalatzis PG, Bastías R, Kokkari C, Katharios P. Isolation and characterization of two lytic bacteriophages, φSt2 and φGrn1; phage therapy application for biological control of Vibrio alginolyticus in aquaculture live feeds. PLoS One. 2016;11 (3):e0151101. DOI: 10.1371/journal.pone.0151101. eCollection 2016 - 59.
Plaza N, Castillo D, Pérez Reytor D, Higuera G, García K, Bastías R. Bacteriophages in the control of pathogenic vibrios. Electronic Journal of Biotechnology. 2018; 31 :24-33. DOI: 10.1016/j.ejbt.2017.10.012 - 60.
Kim SG, Jun JW, Giri SS, Yun S, Kim HJ, Kim SW, et al. Isolation and characterisation of pVa-21, a giant bacteriophage with anti-biofilm potential against Vibrio alginolyticus . Scientific Reports. 2019;9 :6284 - 61.
Reardon S. Phage therapy gets revitalized. The rise of antibiotic resistance rekindles interest in a century-old virus treatment. Nature. 2014; 510 :15-16 - 62.
Sulakvelidze A, Alavidze Z, Morris JG Jr. Bacteriophage therapy. Antimicrobial Agents and Chemotherapy. 2001; 45 (3):649-659 - 63.
Srinivasan P, Ramasamy P. Occurrence, distribution and antibiotic resistance patterns of Vibrio species associated with viral diseased shrimp of south Indian aquaculture environment. International Journal of Agriculture Sciences. 2009;1 (2):1-10 - 64.
Gemmell CG, Edwards DI, Fraise AP, Gould FK, Ridgway GL, Warren RE, et al. Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. Journal of Antimicrobial Chemotherapy. 2006;57 (4):589-608 - 65.
Lodise TP, McKinnon PS. Burden of methicillin-resistant Staphylococcus aureus : Focus on clinical and economic outcomes. Pharmacotherapy. 2007;27 :1001-1012 - 66.
Międzybrodzki R, Fortuna W, Weber-Dąbrowska B, Górski A. Phage therapy of staphylococcal infections (including MRSA) may be less expensive than antibiotic treatment. Postepy Hig Med Dosw. 2007; 61 :461-465 - 67.
Smith HW, Huggins MB. Successful treatment of experimental Escherichia coli infections in mice using phage: Its general superiority over antibiotics. Journal of General Microbiology. 1982;128 :307-318 - 68.
Holmström K, Gräslund S, Wahlström A, et al. Antibiotic use in shrimp farming and implications for environmental impacts and human health. International Journal of Food Science and Technology. 2003; 38 (3):255-266 - 69.
Karunasagar I, Pai R, Malathi GR, et al. Mass mortality of Penaeus monodon larvae due to antibiotic-resistantVibrio harveyi infection. Aquaculture. 1994;128 (3-4):203-209 - 70.
Jayakumar R, Ramasamy P. Prevalence, biotyping and resistotyping of Pseudomonas spp. andVibrio sp isolated fromPenaeus indicus of Ennore Estuary, Madras, India. In: Chou LM, Munro AD, Lam TJ, Chen TW, Cheong LKK, Ding JK, et al. editors. Proceedings of Third Asian Fisheries Forum, Singapore. 1994. pp. 335-338 - 71.
Vaseeharan B, Ramasamy P, Murugan T, Chen JC. In vitro susceptibility of antibiotics againstVibrio spp. andAeromonas spp. isolated fromPenaeus monodon hatcheries and ponds. International Journal of Antimicrobial Agents. 2005;26 :285-291 - 72.
Ramasamy P, Sujatha Rani J, Gunasekaran DR. Assessment of antibiotic sensitivity and pathogenicity of Vibrio spp. andAeromonas spp. from aquaculture environment. MOJ Ecology & Environmental Sciences. 2018;3 (3):128-136 - 73.
Vaseeharana B, Lin J, Ramasamy P. Effect of probiotics, antibiotic sensitivity, pathogenicity, and plasmid profiles of Listonella anguillarum-like bacteria isolated fromPenaeus monodon culture systems. Aquaculture. 2004;241 :77-91 - 74.
Verschuere L, Rombaut G, Sorgeloos P, et al. Probiotic bacteria as biological control agents in aquaculture. Microbiology and Molecular Biology Reviews. 2000; 64 (4):655-671 - 75.
Rengipipat S, Rukpratanporn S, Piyatiratitivorakul S, Menasaveta P. Immunity enhancement in black tiger shrimp ( Penaeus monodon ) by a probiont bacterium (Bacillus S11). Aquaculture. 2000;191 :271-288 - 76.
Gatesoupe FJ. The use of probiotics in aquaculture. Aquaculture. 1999; 180 (1-2):147-165 - 77.
Adamek Z. Effect of ascogen probiotics supplementation on the growth rate of rainbow trout Oncorhynchus mykiss under conditions of intensive culture. Zivocisna Vyroba. 1994;39 (3):247-253 - 78.
Balcázar JL, De Blas I, Ruiz-Zarzuela I, Cunningham D, Vendrell D, Múzquiz JL. The role of probiotics in aquaculture. Veterinary Microbiology. 2006; 114 :173-186. DOI: 10.1016/j.vetmic.2006.01.009 - 79.
Van Hai N, Buller N, Fotedar R. The use of customised probiotics in the cultivation of western king prawns ( Penaeus latisulcatus Kishinouye, 1896). Fish & Shellfish Immunology. 2009;27 :100-104 - 80.
Nayak SK. Probiotics and immunity: A fish perspective. Fish & Shellfish Immunology. 2010; 29 (1):2-14 - 81.
Magnadottir B. Immunological control of fish diseases. Marine Biotechnology (New York, N.Y.). 2010; 12 (4):361-379 - 82.
Chapman CM, Gibson GR, Rowland I. Health benefits of probiotics: Are mixtures more effective than single strains? European Journal of Nutrition. 2011; 50 (1):1-17 - 83.
Fjellheim AJ, Klinkenberg G, Skjermo J, Aasen IM, Vadstein O. Selection of candidate probionts by two different screening strategies from Atlantic cod ( Gadusmorhua L.) larvae. Veterinary Microbiology. 2010;144 :153-159 - 84.
Heidarieh M, Afsharnasab M, Soltani M, Dashtyannasab A, Rajabifar S, Sheikhzadeh N, et al. Effects of ergosan and vibromax to prevent vibriosis and WSSV in Litopenaeus vannamei . Journal of Fisheries and Aquatic Science. 2010;5 :120-125 - 85.
Fuller R. History and development of probiotics. In: Probiotics. Netherlands: Springer; 1992. pp. 1-8 - 86.
Robles R, Sorgeloos P, Van Duffel H, Nelis H. Progress in biomedication using live foods. Journal of Applied Ichthyology. 1998; 14 :207-212 - 87.
Green A, Green M. Probiotics in Asian shrimp aquaculture. MPEDA Newsletter; 2003 - 88.
Haung HJ. Important tools to the success of shrimp aquaculture—Aeration and the applications of tea seed cake and probiotics. Aquaculture International. 2003:13-16 - 89.
Ahilan B. Probiotics in aquaculture. Aquaculture International. 2003:39-40 - 90.
Mishra S, Mohanty S, Pattnaik P, Ayyappan S. Probiotics—Possible role in aquaculture. Fishing Chimes. 2001; 21 (1):31-36 - 91.
Jameson JD. Role of probiotics in aquaculture practices. Fishing Chimes. 2003; 23 :9 - 92.
Shakibazadeh S, Saad CR, Christianus A, Kamarudin MS, Sijam K, Sinaian P. Assessment of possible human risk of probiotic application in shrimp farming. International Food Research Journal. 2011; 18 :433-437 - 93.
Kumar V, Roy S, Meena DK, Sarkar UK. Application of probiotics in shrimp aquaculture: Importance, mechanisms of action, and methods of administration. Reviews in Fisheries Science & Aquaculture. 2016; 24 (4):342-368. DOI: 10.1080/23308249.2016.1193841 - 94.
Nogami K, Maeda M. Bacteria as biocontrol agents for rearing larvae of the crab Portunus trituberculatus . Canadian Journal of Fisheries and Aquatic Sciences. 2011;49 (11):2373-2376. DOI: 10.1139/f92-261 - 95.
Nogami K, Hamasaki K, Maeda M, Hirayama K. Biocontrol method in aquaculture for rearing the swimming crab larvae Portunus trituberculatus . Hydrobiologia. 1997;358 :291-295 - 96.
Nogami K, Hamasaki K, Maeda M, Hirayama K. Biocontrol method in aquaculture for rearing the swimming crab larvae Portunus trituberculatus . In: Hagiwara A, Snell TW, Lubzens E, Tamaru CS, editors. Live Food in Aquaculture. Developments in Hydrobiology. Vol. 124. Dordrecht: Springer; 1997 - 97.
Martínez-Díaz SF, Hipólito-Morales A. Efficacy of phage therapy to prevent mortality during the vibriosis of brine shrimp. Aquaculture. 2013; 400-401 :120-124. DOI: 10.1016/j.aquaculture.2013.03.007 - 98.
Quiroz-Guzmán E, Peña-Rodriguez A, Vázquez-Juárez R, Barajas-Sandoval DR, Balcázar JL, Martínez-Díaz SF. Bacteriophage cocktails as an environmentally-friendly approach to prevent Vibrio parahaemolyticus andVibrio harveyi infections in brine shrimp (Artemia franciscana ) production. Aquaculture. 2018:273-279. DOI: 10.1016/j.aquaculture.2018.04.025 - 99.
Quiroz Guzman E, Peña A, Vázquez-Juárez R, Martínez-Díaz SF. Bacteriophage cocktails as an environmentally-friendly approach to prevent Vibrio parahaemolyticus andVibrio harveyi infections in brine shrimp (Artemia franciscana ) production. Aquaculture. 2018;492 :273-279 - 100.
Oakey HJ, Cullen BR, Owens L. The complete nucleotide sequence of the Vibrio harveyi bacteriophage VHML. Journal of Applied Microbiology. 2002;93 (6):1089-1098 - 101.
Stalin N, Srinivasan P. Characterization of Vibrio parahaemolyticus and its specific phage from shrimp pond in Palk Strait, South East coast of India. Biologicals. 2016;44 (6):1-8. DOI: 10.1016/j.biologicals.2016.08.003